Evidence map›Paper›PMID 18572395›Full record

ReviewCurrent opinion in immunology2008

Role of chaperones and FcgammaR in immunogenic death.

Madhav V Dhodapkar, Kavita M Dhodapkar, Zihai Li

Abstract readReview
In one paragraph

Review in Current opinion in immunology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Madhav V DhodapkarSection of Hematology, Yale University, New Haven, CT, USA. madhav.dhodapkar@yale.edu
Kavita M Dhodapkar
Zihai Li

Funding

Roles and Mechanisms of gp96 in Chaperoning Innate ImmunityR01AI070603 · NIAID · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI LI, ZIHAI · 2007 to 2016
$3.8M
Anti-Tumor immunity in myelomaR01CA106802 · NCI · YALE UNIVERSITY · PI DHODAPKAR, MADHAV V · 2004 to 2016
$3.3M
Targeting myeloma via dendritic cellsR01CA109465 · NCI · YALE UNIVERSITY · PI DHODAPKAR, MADHAV V · 2005 to 2009
$1.6M
Immunity to stem cell antigens in preneoplastic gammopathyR01CA135110 · NCI · YALE UNIVERSITY · PI DHODAPKAR, MADHAV V · 2008 to 2013
$1.6M
Role of cell surface HSP gp96 in immunityR01CA100191 · NCI · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI LI, ZIHAI · 2004 to 2007
$933k
Immune resistance to glioma via dendritic cellsK08AI054375 · NIAID · YALE UNIVERSITY · PI DHODAPKAR, KAVITA MADHAV · 2004 to 2008
$631k
NCI NIH HHS CA100191NCI NIH HHS CA106802NCI NIH HHS CA109465NCI NIH HHS R01 CA100191NCI NIH HHS R01 CA106802NCI NIH HHS R01 CA109465NCI NIH HHS R01 CA135110NIAID NIH HHS AI054375NIAID NIH HHS AI070603NIAID NIH HHS K08 AI054375NIAID NIH HHS R01 AI070603
6 · The paper itself

Abstract

Cell death under physiologic conditions does not lead to the induction of immunity. However recognition of stressed or opsonized cells can trigger immune responses. Recent studies have begun to illustrate the critical role of molecular chaperones such as inducible heat shock proteins in mediating immunogenicity of stressed cells. Immunity to opsonized cells depends in part on the engagement and the balance of activating and inhibitory FcgammaRs on antigen presenting dendritic cells. Understanding both these pathways of immunogenic cell death may yield novel approaches to regulate immunity.

Indexed as

AnimalsAntigen-Antibody ReactionsAntigen-Presenting CellsApoptosisHeat-Shock ProteinsHumansMolecular ChaperonesReceptors, IgGHeat-Shock ProteinsMolecular ChaperonesReceptors, IgG

Identifiers

PMID18572395
PMCPMC3224819

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.